We serve (2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone CAS:915095-87-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![(2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone](https://a.dearchem.com/uploads/userup/0/15LPYP-6321.png)
Chemical Name: (2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone
CAS.NO: 915095-87-3
Synonyms:
(S)-(2-Chloro-5-iodophenyl)(4-(tetrahydrofuran-3-yloxy)phenyl)methanone
Empagliflozin intermediate
(2-CHLORO-5-IODOPHENYL)[4-[[(3S)-TETRAHYDRO-3-FURANYL)OXY]PHENYL]METHANONE
Methanone, (2-chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]-
Molecular Formula: C17H14ClIO3
Molecular Weight: 428.64900
Physical and Chemical Properties:
Density: 1.639±0.1 g/cm3
BBoiling point: 525.9±50.0 °C (760 mmHg)
Melting point: /
Flash point: 272℃
Refractive index: /
Specification:
Appearance:White Powder
Purity:≥99.0%
Total Impurity:≤0.5%
Water:≤0.5%
Heavy metals:≤10ppm
Volatile:≤0.1%
Inorganic salt:≤0.1%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Keep in cool & dry place.Keep away from strong light and heat.
Application:Intermediates of Empagliflozin CAS:864070-44-0.
Contact us for information like (2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methanone, (2-chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone Use and application,(S)-(2-Chloro-5-iodophenyl)(4-(tetrahydrofuran-3-yloxy)phenyl)methanone technical grade,usp/ep/jp grade.
Related News: As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured.1H,1H,2H,2H-Perfluorooctyltriethoxysilane manufacturer In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.1-Bromo-3,3-Dimethyl-Butane supplier In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.4-phenylbutyric acid vendor Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.
